Across rheumatic diseases

Association of anti-Ro52 antibody with depression and anxiety in patients with connective tissue diseases: an observational, single-centre, cross-sectional study

Clin Exp RheumatolPublished Cross-sectional study

Main finding · Depression (PHQ-9 ≥ 5): anti-Ro52 antibody as risk factorResult — go to the resultOdds ratio 5.466 95% CI 2.978~10.032

Authors' conclusion

Anti-Ro52 antibody is probably a risk factor for depression and anxiety in patients with connective tissue diseases. CTD patients with the presence of anti-Ro52 antibody are more prone to depression and anxiety than those without it.

Study context

Population
Inpatients with connective tissue diseases (CTDs)inpatients with CTDs
Participants
352 inpatients
Exposure
Anti-Ro52 antibody present vs absent
  • CTDn = 352
Outcome
Depression (PHQ-9 ≥ 5) and anxiety (GAD-7 ≥5) and their risk factors, especially serum autoantibodies
Methodological detailsobservational, single-centre, logistic regression
  • Observational
  • Single-centre
  • Logistic regression

Main finding

As reported in the abstract

Depression (PHQ-9 ≥ 5): anti-Ro52 antibody as risk factor

Odds ratio

5.466

95% CI 2.978~10.032

P < 0.001

Anti-Ro52 positivevs Anti-Ro52 negative
OR 5.466 (95% CI 2.978~10.032); P < 0.001

Observational data: associations, not effects.

Further findings

OutcomeOR (95% CI)P value
Anxiety (GAD-7 ≥5): anti-Ro52 antibody as risk factorAnti-Ro52 positivevs Anti-Ro52 negative4.075 (2.073~8.010)P < 0.001

Sleep time as protective factor for depression

OR (95% CI)P value
Sleep time0.734 (0.616~0.874)P < 0.001

Sleep time as protective factor for anxiety

OR (95% CI)P value
Sleep time0.684 (0.559~0.835)P < 0.001

Prevalence of depression and anxiety, CTD patients vs Chinese general population

Depression: CTD patients vs Chinese general population
44.3% vs. 32.2%
Anxiety: CTD patients vs Chinese general population
39.5% vs. 22.2%
  • Significantly higher than in the Chinese general population

Anti-Ro52 and depression/anxiety in subgroups (SLE, SS, RA, other CTDs)

Anti-Ro52 antibody was a risk factor for depression and anxiety in all four subgroups

Original publication

Association of anti-Ro52 antibody with depression and anxiety in patients with connective tissue diseases: an observational, single-centre, cross-sectional study. Clin Exp Rheumatol. Published 25 August 2023. doi:10.55563/clinexprheumatol/be9n92

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.